Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA036915-03S1
Application #
3174557
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1984-03-01
Project End
1988-01-31
Budget Start
1987-12-01
Budget End
1988-01-31
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Stanford University
Department
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Neubauer, A; Greenberg, P; Negrin, R et al. (1994) Mutations in the ras proto-oncogenes in patients with myelodysplastic syndromes. Leukemia 8:638-41
Greenberg, P L (1992) In vitro marrow culture studies in the myelodysplastic syndromes. Semin Oncol 19:34-46
Nagler, A; Binet, C; Mackichan, M L et al. (1990) Impact of marrow cytogenetics and morphology on in vitro hematopoiesis in the myelodysplastic syndromes: comparison between recombinant human granulocyte colony-stimulating factor (CSF) and granulocyte-monocyte CSF. Blood 76:1299-307
Lewinsohn, D M; Nagler, A; Ginzton, N et al. (1990) Hematopoietic progenitor cell expression of the H-CAM (CD44) homing-associated adhesion molecule. Blood 75:589-95
Greenberg, P; Negrin, R; Nagler, A et al. (1990) Effects of treatment of myelodysplastic syndromes with recombinant human granulocyte colony stimulating factor. Prog Clin Biol Res 338:151-61
Negrin, R S; Haeuber, D H; Nagler, A et al. (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76:36-43
Oksenberg, D; Dieckmann, B S; Greenberg, P L (1990) Functional interactions between colony-stimulating factors and the insulin family hormones for human myeloid leukemic cells. Cancer Res 50:6471-7
Greenberg, P L; Negrin, R; Nagler, A (1990) Effects of CSFs in preleukemia. Bone Marrow Transplant 6 Suppl 1:121-6
Nagler, A; Ginzton, N; Negrin, R et al. (1990) Effects of recombinant human granulocyte colony stimulating factor and granulocyte-monocyte colony stimulating factor on in vitro hemopoiesis in the myelodysplastic syndromes. Leukemia 4:193-202
Greenberg, P; Negrin, R; Nagler, A et al. (1990) Effects of prolonged treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Int J Cell Cloning 8 Suppl 1:293-300;discussion 300-2

Showing the most recent 10 out of 20 publications